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Abstract
Background: Spermatogonial stem cells (SSCs) have the unique ability to undergo self-renewal division. However, these
cells are morphologically indistinguishable from committed spermatogonia, which have limited mitotic activity. To establish
a system for SSC purification, we analyzed the expression of SSC markers CD9 and epithelial cell adhesion molecule
(EPCAM), both of which are also expressed on embryonic stem (ES) cells. We examined the correlation between their
expression patterns and SSC activities.
Methodology and Principal Findings: By magnetic cell sorting, we found that EPCAM-selected mouse germ cells have
limited clonogenic potential in vitro. Moreover, these cells showed stronger expression of progenitor markers than CD9-
selected cells, which are significantly more enriched in SSCs. Fluorescence-activated cell sorting of CD9-selected cells
indicated a significantly higher frequency of SSCs among the CD9
+EPCAM
low/- population than among the CD9
+EPCAM
+
population. Overexpression of the active form of EPCAM in germline stem (GS) cell cultures did not significantly influence
SSC activity, whereas EPCAM suppression by short hairpin RNA compromised GS cell proliferation and increased the
concentration of SSCs, as revealed by germ cell transplantation.
Conclusions/Significance: These results show that SSCs are the most concentrated in CD9
+EPCAM
low/- population and also
suggest that EPCAM plays an important role in progenitor cell amplification in the mouse spermatogenic system. The
establishment of a method to distinguish progenitor spermatogonia from SSCs will be useful for developing an improved
purification strategy for SSCs from testis cells.
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Introduction
Spermatogonial stem cells (SSCs) account for a small population
of testis cells [1,2], and their self-renewal activity distinguishes
them from committed progenitor cells. Spermatogonia, the most
undifferentiated germ cells in testes, contain both SSCs and
progenitor cells. SSCs are able to reproduce themselves while
producing progenitor cells, thereby maintaining a constant
population size. In contrast, progenitor spermatogonia disappear
after several rounds of mitotic division. Self-renewal activity is
defined only through retrospective analysis of daughter cells,
making it difficult or impossible to identify SSCs by morphological
observation.
In 1994, a germ cell transplantation technique was developed,
in which donor testis cells recolonize seminiferous tubules
following microinjection into the testes of infertile recipients [3].
This provided the first functional assay for SSCs. The estimated
number of SSCs was 2610
3 to 3610
3 per testis, which represents
,10% of the total Asingle (As) spermatogonia, suggesting that only
a small population of As cells have SSC activity [2,4,5]. Using the
functional transplantation assay, SSCs were subsequently analyzed
for the expression of cell surface markers by selecting cells with
monoclonal antibodies against surface antigens [6,7]. Although no
SSC-specific markers have been identified, several markers for
SSCs are available [8], and a combination of positive and negative
selection by surface antigens has allowed the purification of SSCs
to 1 in 15 to 30 purified cells [6,7]. However, the degree of
enrichment achieved using individual antigens is limited and
ranges from 1:625 to 1:1250 [6–8], suggesting that committed
spermatogonia express similar markers.
In this study, we analyzed the expression of CD9 and epithelial
cell adhesion molecule (EPCAM) on SSCs. CD9 is a member of
the tetraspanin family molecules and is expressed on mouse and
rat SSCs [9]. On the other hand, EPCAM is a homophilic,
calcium-independent cell adhesion molecule and is uniquely
expressed on the germline cells from the embryonic stages of
germ cell development. Its expression in the postnatal testis
continues until the spermatocyte stage [10]. Although both of
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more useful marker for purifying rat SSCs [11]. However, while
attempting to initiate SSC cultures from mouse testes, we observed
that EPCAM-expressing cells had limited ability to produce
spermatogonial colonies. Flow cytometric analysis revealed that
EPCAM expression changed dynamically during spermatogonial
differentiation. Here, the identity of EPCAM-expressing cells was
determined by germ cell transplantation assay, and the function of
EPCAM was analyzed by in vitro spermatogonial culture.
Materials and Methods
Ethics statement
We followed the Fundamental Guidelines for Proper Conduct
of Animal Experiment and Related Activities in Academic
Research Institutions under the jurisdiction of the Ministry of
Education, Culture, Sports, Science and Technology, and all of
the protocols for animal handling and treatment were reviewed
and approved by the Animal Care and Use Committee of Kyoto
University (Med Kyo 11079).
Animals
ICR mice (Japan SLC, Shizuoka, Japan) were used for primary
testis cell culture. Transgenic mouse line C57BL/6 Tg14(act-
EGFP)OsbY01 (designated as Green; a gift from Dr. M. Okabe,
Osaka University, Osaka, Japan) was used for transplantation
experiments using magnetic cell sorting (MACS). Transgenic
mouse line B6-TgR(ROSA26)26Sor (designated as ROSA;
purchased from the Jackson Laboratory, Bar Harbor, ME) was
used for fluorescence-activated cell sorting (FACS) experiments to
avoid interference of enhanced green fluorescent protein (EGFP)
fluorescence for multiparameter sorting. ROSA mice that were
backcrossed to the DBA/2 background for more than eight
generations were used for derivation of germline stem (GS) cells
[12]. WBB6F1-W/W
v (W) mice (Japan SLC) were used as
recipients for germ cell transplantation.
Cell culture
For characterization of spermatogonia in the pup testis, testis
cells were prepared from 7- to 10-day-old male mice. Single-cell
suspensions were obtained by two-step enzymatic digestion using
collagenase type IV (1 mg/ml) and trypsin (0.25%), as described
previously [12,13]. Cells were plated at 3610
5 cells / well of 6-well
culture plates, which have been coated with laminin (20 mg/ml;
BD Biosciences, Franklin Lakes, NJ). GS cells were derived from
ROSA mice, and were maintained on mitomycin C-treated mouse
embryonic fibroblasts (MEFs) [12,13]. Culture medium was
prepared by modifying commercial medium (StemPro
H-34
serum-free medium (SFM); Invitrogen, Carlsbad, CA) as described
previously [12,13]. Growth factors used were human fibroblast
growth factor 2 (FGF2;10 ng/ml) and rat glial cell line-derived
neurotrophic factor (GDNF; 15 ng/ml; both from Peprotech,
Rocky Hill, NJ).
For overexpression of the intracellular fragment of EPCAM
(EpICD) [14], the cDNA fragment encoding EpICD (a gift from
Dr. O. Gires, Ludwig Maximilian University of Munich,
Germany) was cloned into CSII-EF-IRES2-Venus vector. Lentivirus
particles were produced by transient transfection of 293T cells,
and GS cells from ROSA mice (ROSA GS cells) were transfected,
as described previously [15]. For EpICD overexpression experi-
ments, the virus titer was determined by transfecting 293T cells,
and the multiplicities of infection (MOI) was adjusted to 2.0. For
short hairpin RNA (shRNA)-mediated gene knockdown (KD), the
Epcam KD vectors TRCN0000111220, TRCN0000111221,
TRCN0000111222, TRCN0000111223, and TRCN0000111224
were purchased from Open Biosystems (Huntsville, AL). A
mixture of lentivirus particles was used to transfect GS cells from
ROSA mice, and 3 independent samples were examined. A
lentivirus expressing shRNA against EGFP was used as a control
(Open Biosystems). The lentivirus titer was determined using a
Lenti-X p24 rapid titer kit (Clontech, Mountain View, CA). The
MOI in the KD experiment was adjusted to 24.0.
Cell separation and flow cytometry
Testis cells were prepared from 5- to 10-week-old male mice.
MACS was performed as described previously using rat anti-
mouse EPCAM (G8.8; Biolegend, San Diego, CA) or rat anti-
mouse CD9 (KMC8; BD Biosciences) antibodies [9,16]. Sheep
anti-rat IgG Dynabeads (Invitrogen) were used for in vitro culture,
and goat anti-rat IgG microbeads (Miltenyi Biotech, Gladbach,
Germany) were used as a secondary antibody for FACS
experiments. The average recovery was determined by four
experiments.
For analyses of cell surface antigens, CD9- or EPCAM-selected
cells were incubated with the following antibodies: rat anti-mouse
CD9 (2B8; BD Biosciences), rat anti-mouse EPCAM (G8.8;
Biolegend), mouse anti-mouse FUT4 (SSEA1; MC-480;
eBioscience, San Diego, CA), biotin-conjugated anti-mouse
ITGB1 (Ha2/5; BD Biosciences), and rat anti-mouse ITGA6
(GoH3; BD Biosciences). Secondary reagents were: allophycocya-
nin (APC)-conjugated anti-rat IgG, APC-conjugated streptavidin,
and APC-conjugated anti-mouse IgM (all from BD Biosciences).
For double immunostaining, CD9-selected cells were incubated
with APC-conjugated rat ant-CD9 and phycoerythrin (PE)-
conjugated anti-EPCAM antibodies. PE-Cy7-conjugated KIT
antibody (eBioscience) was used to evaluate KIT expression in
subfractionated cells. The cells were incubated in ice-cold
phosphate-buffered saline/1% fetal bovine serum (PBS/1%
FBS). EpICD-transfected ROSA GS cells were sorted according
to Venus expression. Propidium iodide (1 mg/ml; Sigma, St. Louis,
MO) was added to exclude dead cells. Stained cells were analyzed
by FACSCalibur or sorted by FACSAria II (both from BD
Biosciences).
Apoptosis assay
For terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining, single cell suspension was concentrat-
ed on glass slides by centrifugation with Cytospin 4 (Thermo
Electron Corporation, Cheshire, UK). After fixation in 4%
paraformaldehyde for 1 h, cells were then labeled using an In
situ Cell Death Detection kit; TMR red (Roche Applied Science,
Mannheim, Germany) following the manufacturer’s protocol. The
cells were couterstained with Hoechst 33342 (2 mg/ml; Sigma) to
determine the percentage of TUNEL-positive nuclei relative to the
total number of cells. Apoptotic cells were quantified by collecting
three images using Photoshop software (Adobe Systems, San Jose,
CA). At least 200 cells were counted for each sample.
Germ cell transplantation
Germ cell transplantation was performed by microinjection into
the seminiferous tubules via the efferent duct [17]. Approximately
75–85% of the tubules were filled in each recipient testis. At least
three experiments were carried out for MACS and FACS. In
experiments using GS cells, recipient mice were treated with anti-
CD4 antibody (GK1.5; gift from Dr. T. Honjo, Kyoto University)
to avoid rejection of allogeneic donor cells [18]. The Institutional
Animal Care and Use Committee of Kyoto University approved
all of the animal experiment protocols.
EPCAM on Spermatogonia
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In experiments using ROSA mice, the recipient testes were
fixed with 4% paraformaldehyde for 2 h, and LacZ staining was
performed using 5-bromo-4-chloro-3-indolyl ß-D-galactoside (X-
Gal) (Wako Pure Chemical Industries, Osaka, Japan), as described
previously [5]. In experiments using Green mice, the recipient
testes were analyzed under UV light. These methods specifically
identify donor cells, because host cells do not stain for LacZ and
lack green fluorescence. We defined colonies as donor cell clusters
longer than 0.1 mm occupying the entire circumference of the
seminiferous tubule. Results were obtained from analyses of 10–12
recipient testes in at least two experiments. For histological
analyses, samples were embedded in paraffin blocks and sectioned.
The sections were counterstained with hematoxylin and eosin.
Analysis of gene expression
Total RNA was extracted using Trizol, and first-strand cDNA
was synthesized by reverse transcription with Superscript
TM II
(both from Invitrogen) for reverse transcriptase-polymerase chain
reaction (RT-PCR). For quantifying mRNA expression using real-
time PCR, a StepOnePlus
TM Real-Time PCR system and Power
SYBR Green PCR Master Mix were used according to the
manufacturer’s protocol (Applied Biosystems, Warrington, UK).
Transcript levels were normalized to that of Hprt, with expression
levels in EPCAM-selected cells. The PCR conditions were 95uC
for 10 min, followed by 40 cycles of 95uC for 15 s and 60uC for
1 min. Each PCR was run at least in triplicate using specific
primers (Table S1).
Statistical analysis
The results were presented as means6SEM. Independent
samples with equal variance were analyzed using the Student’s t-
test. SSC activity of subfractionated cells was analyzed by
ANOVA followed by Tukey’s HSD.
Results
Reduced SSC potential of EPCAM
+ cells
Testicular somatic cells often overwhelm growth of proliferating
germ cells in vitro [12]. To establish an improved strategy for SSC
culture initiation, we assumed that EPCAM would be a useful
selection marker because it is thought to be expressed specifically
in germ cells, including SSCs [8,10]. In preliminary experiments,
we used anti-EPCAM antibody to collect EPCAM-expressing
germ cells from pup testes, which are relatively enriched for SSCs
owing to the absence of differentiating germ cells [19]. Testis cells
were prepared from 7-day-old pups, and EPCAM-expressing cells
were collected by MACS. The cells were cultured on laminin-
coated plates. Although CD9-selected cells contained testicular
somatic cells that over-proliferated and interfered with germ cell
proliferation in culture, the majority of the EPCAM-selected cells
consisted of a pure population of germ cells; only a few somatic
cells were found (Fig. 1A). However, proliferation of the EPCAM-
selected cells was limited, and many of the cells eventually
underwent apoptosis, which was identified by TUNEL staining
(5.060.8% vs. 28.760.4%, respectively, for CD9- and EPCAM-
selected cells; Fig. 1B). In contrast, cultures initiated with CD9-
selected cells exhibited typical spermatogonial proliferation and
colony growth by 7–10 days.
As these results indicated that EPCAM-selected cells have
limited clonogenic potential in vitro, we characterized the
EPCAM- and CD9-selected cells. EPCAM- and CD9-expressing
cells were collected by MACS and stained for several cell surface
markers known to be expressed on germline cells [8,20] (Fig. 1C).
Although both EPCAM- and CD9-selected cells expressed
markers of SSCs, expression of KIT, which is a marker for
progenitor spermatogonia [20], was stronger in EPCAM-selected
cells, which suggested that they included more progenitor
spermatogonia. In addition, CD9-selected cells also contained a
significant proportion of cells that did not express EPCAM. Real-
time PCR analysis of genes thought to be involved in SSC self-
renewal and differentiation revealed reduced expression of Nanos3,
Bcl6b, and Etv5 in EPCAM-selected cells [8,21–23] (Fig. 1D). The
expression levels of Ccnd1 and Ccnd2, which influence SSC activity
[24], were also downregulated. These results suggest that
EPCAM-selected cells have reduced SSC activity.
To directly test this hypothesis, EPCAM- or CD9-expressing
cells were collected and their SSC activities were assessed by germ
cell transplantation. The average recoveries of EPCAM- and
CD9-selected cells were 4.961.0% and 5.960.5% of the total
testis cells, respectively. The selected cells were microinjected into
the seminiferous tubules of congenitally infertile W mouse testes.
Two months later, the recipients were killed, and the number of
colonies in the testes was analyzed under UV fluorescence
(Fig. 1E). EPCAM-selected cells produced significantly more
colonies compared with non-selected control cells (5.761.0 vs.
1.960.4 colonies/10
5 transplanted cells, respectively; Fig. 1F). In
contrast, in two transplantation experiments, the CD9-selected
cells resulted in more efficient SSC recovery, producing 29.562.3
colonies/10
5 transplanted cells, which was 32.8 times the number
of colonies from the control cells (0.960.6 colonies). These
experiments suggest that the concentration of SSCs is higher
among CD9-selected cells than EPCAM-selected cells.
Subfractionation of CD9-selected cells by EPCAM
expression level
To investigate the difference between EPCAM- and CD9-
selected cells in the transplantation experiments, we next analyzed
the expression of EPCAM and CD9 in EPCAM- and CD9-
selected cells of ROSA mice recovered by MACS. Flow cytometry
of the double-stained spermatogonial populations was performed
by gating according to cell size (forward scatter) and complexity
(side scatter). As expected from the result of MACS experiments,
CD9-selected cells contained cells with relatively high side scatter
values, which suggested their heterogeneity (Fig. 2A). In contrast,
EPCAM-selected cells were more uniform in size and complexity.
Double-stained CD9-selected cells revealed the presence of at least
three subpopulations (Fig. 2B). Fraction I consisted of cells
exhibiting strong CD9 expression with relatively weak EPCAM
expression. Fraction II, which contained significantly more cells
than fraction I, comprised cells with strong EPCAM expression
and medium CD9 expression. A CD9
low/- population of cells that
lacked EPCAM constituted fraction III. Compared with the CD9-
selected cells, the EPCAM-selected cells showed a distinct forward
scatter/side scatter profile and consisted predominantly of fraction
II cells. They also contained only EPCAM
+ cells of fraction I cells
(Fig. 2A). KIT expression was stronger in fraction II than in
fraction I cells, suggesting that fraction I cells were more
undifferentiated (Fig. 2C). Fraction III showed little KIT
expression (Fig. 2C).
We then analyzed testis cells from three different developmental
stages to examine when these subpopulations appear during
testicular development. We collected testis cells from 1-, 10-, and
35-day-old mice and stained them with CD9 and EPCAM
antibodies (Fig. 2D). Testis cells from 1-day-old mice contained
only gonocytes, and showed predominantly CD9
+ cells, with very
few EPCAM
+ cells. EPCAM
+ cells were found in 10-day-old mouse
testis cells, which contained spermatogonia and spermatocytes, but
EPCAM on Spermatogonia
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23663Figure 1. Characteristics of germ cells after CD9 or EPCAM selection. (A) Appearance of CD9-selected (Left) or EPCAM-selected (Right) germ
cells on laminin-coated dishes, after 7 days in culture. Testis cells were collected from 10-day-old pups and used to initiate GS cell cultures after MACS.
No significant colony formation is seen in EPCAM-selected cells. CD9-selected cells started to proliferate to form spermatogonia chains under the
same culture condition, and spermatogonial chains are seen. Note the contaminating testicular fibroblasts in cultures of CD9-selected cells. Arrows
indicate magnetic beads used for cell separation. (B) Apoptosis of CD9-selected (Left) and EPCAM-selected cells (Right), after 8 days in culture. TUNEL-
positive cells are stained red. Counterstained by Hoechst 33342 (blue). (C) Flow cytometric analyses of CD9-selected (Top) or EPCAM-selected
(Bottom) cells collected from adult testes. Green lines indicate control staining. Note the increased KIT staining in EPCAM-selected cells. (D) Real-time
PCR analyses of spermatogonial marker genes or cyclins in EPCAM- or CD9-selected cells. CD9-selected cells show increased expression of Nanos3,
Bcl6b, Etv5, Ccnd1, and Ccnd2. Transcript levels were normalized to Hprt expression, with expression levels in EPCAM-selected cells. (E) Macroscopic
appearance of recipient testes transplanted with EPCAM- or CD9-selected cells. Green tubules indicate germ cell colonies developed from donor
SSCs. The same numbers of cells were transplanted at the same time. (F) Quantification of colonies. Both EPCAM-selected (Left) and CD9-selected
(Right) cells produced significantly more germ cell colonies than control unselected testis cells, but CD9-selected cells contained a higher
concentration of SSCs. Bars =20 mm (A); 100 mm (B); 1 mm (E).
doi:10.1371/journal.pone.0023663.g001
EPCAM on Spermatogonia
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subpopulations, fraction I (CD9
+EPCAM
low/-) and fraction II
(CD9
lowEPCAM
+), with fraction I being significantly smaller. Testis
cells from 35-day-old mice contained all stages of spermatogenic
cells, and revealed three subpopulations; the relative proportion of
cells in fraction I was smaller than that in 10-day-old mouse testis
cells, possibly reflecting increased production of differentiating
meiotic or haploid cells. These results suggest an enrichment of
fraction I (CD9
+EPCAM
low/-) in spermatogonia.
To determine which CD9-selected cell fraction was enriched for
SSCs, cells from each of the three fractions were transplanted into
the seminiferous tubules of recipient mice. Non-selected total testis
cells were used as a control. Fraction I cells exhibited the highest
SSC activity in recipient testes, producing 86.6624.4 colonies/10
5
transplanted cells (Fig. 3A and B). The concentration of SSCs in
this fraction was ,48.7-fold that in control cells, which produced
1.860.5 colonies/10
5 transplanted cells. Consistent with this
result, microscopic analysis of the sorted cells showed that fraction
I consisted of cells with a relatively uniform appearance and
occasional pseudopod formation (Fig. 3A, inset). Histological
sections confirmed the normal appearance of the transplanted cells
(Fig. 3C). Although fraction II also contained some SSCs (1.160.6
colonies/10
5 cells transplanted), no significant enrichment was
observed compared with non-selected control testis cells. Fraction
III cells had no SSC activity.
Analysis of EPCAM function
To investigate the function of EPCAM, we used the GS cell
culture system, in which SSCs increase their numbers exponen-
tially in vitro in the presence of GDNF and FGF2 [12]. GS cells
were previously shown to express EPCAM, and 1–2% of GS cells
had SSC activity [12,25]. Flow cytometric analyses showed that
the EPCAM expression level in GS cells was upregulated by
supplementation with GDNF, whereas FGF2 showed no apparent
effect (Fig. 4A).
Considering the expression of EPCAM on embryonic stem (ES)
cells and rat SSCs, we examined whether stimulation of EPCAM
increases SSC activity. GS cells from ROSA mice were infected
Figure 2. Flow cytometric analyses of CD9- or EPCAM-selected cells after MACS. (A) Light-scattering properties and double
immunostaining of total testis cells (Top), CD9-selected cells (Middle) or EPCAM-selected cells (Bottom) stained with APC-conjugated anti-CD9 and
PE-conjugated anti-EPCAM antibodies. Cells were gated according to forward scatter (size) and side scatter (cell complexity) values (Left). Gated cells
were analyzed for CD9 and EPCAM (Right). Note the simpler light-scattering properties of EPCAM-selected cells. (B) Three subpopulations of CD9-
selected cells. Fraction I shows high CD9 and low or no EPCAM immunostaining; fraction II shows low CD9 and high EPCAM immunostaining; and
fraction III is low or no CD9 and no EPCAM immunostaining. (C) The three CD9-selected cell subpopulations, immunostained with APC-conjugated
anti-CD9, PE-conjugated anti-EPCAM, and PE-Cy7-conjugated anti-KIT antibodies. KIT is strongly expressed in fraction II. Areas shaded in black
indicate control staining. (D) Changes in immunostaining of total testis cells during postnatal testicular development. Total testis cells were stained
with APC-conjugated anti-CD9 and PE-conjugated anti-EPCAM antibodies. Stronger CD9 and EPCAM immunostaining is seen in 10-day-old mouse
testis cells compared with 1-day-old mouse testis cells. Only testes from 35-day-old mice show all three fractions.
doi:10.1371/journal.pone.0023663.g002
Figure 3. Functional analyses of SSC activity by germ cell transplantation of each CD9-selected cell fraction. (A) Macroscopic
appearance of recipient testes. Approximately 4.9610
3, 2.3610
4, 3.5610
2, and 1.6610
5 cells were transplanted for fractions I, II, III, and control cells,
respectively. Recipient testes were stained with X-Gal 2 months after transplantation. Blue tubules indicate germ cell colonies developed from donor
SSCs. Cells in fraction I have a uniform appearance (insert). (B) Quantification of colonies. The number of cells that could be recovered in each
experiment varied, and thus the colony number was normalized to reflect donor cells at a concentration of 10
5 cells injected/testis. Cells in fraction I
are significantly enriched for SSCs. (C) Histological sections of recipient testes. Note the normal appearance of spermatogenesis of donor-derived cells
in recipients of control cells (Top) and fraction I cells (Bottom). Stain: X-Gal (A); X-Gal, Hematoxylin and eosin (C). Bars =1 mm (A), 50 mm (C).
doi:10.1371/journal.pone.0023663.g003
EPCAM on Spermatogonia
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(EpICD) as well as Venus protein under the control of the EF-1
apromoter. Normally in cells, EpICD is normally cleaved after
EPCAM activation, and thus the EpICD protein can transmit the
signal to the nucleus. Venus-expressing cells were purified and
cultured in vitro for expansion (Fig. 4B and C). However, the
transfected cells did not undergo a significant change in cell or
colony morphology (Fig. 4C). In addition, flow cytometric analyses
showed no change in the expression level of EPCAM or any other
spermatogonial marker examined (Fig. 4D). There were no
significant changes in gene expression patterns as determined by
RT-PCR or in responses to exogenous cytokines (Fig. 4E and F)
[8,26].
To look at the effect of EPCAM stimulation on SSC self-
renewal, we transplanted EpICD-expressing GS cells into
seminiferous tubules in two experiments. LacZ staining of the
recipient testes showed that the numbers of colonies generated
from EpICD-GS and control GS cells were 210.468.4 and
298.1634.1/10
5 transplanted cells, respectively. The value for
EpICD-GS cells was not significantly different from control value
(Fig. 4G and H). Histological analysis of the recipient testes
showed normal spermatogenesis (Fig. 4I). Thus, overexpression of
EpICD did not appear to change SSC activity.
In the second set of experiments, we used shRNA to inhibit
EPCAM expression. Transfection of ROSA GS cells with Epcam
KD lentivirus vector significantly suppressed EPCAM expression
within 2 days (Fig. 5A and B). EPCAM downregulation suppressed
the proliferation/survival of GS cells (Fig. 5C). Only 30.467.6%
of the input cells were recovered after Epcam KD treatment,
whereas 73.868.8% of the input cells could be recovered after
control shRNA treatment. These results indicate that EPCAM
plays a role in the proliferation or survival of GS cells.
We next evaluated the SSC activity by transplanting the Epcam
KD-transfected cells into the seminiferous tubules. Two days after
infection, the cultured cells were transplanted into the testes of W
mice. In two separate experiments, Epcam KD cells and control GS
cells generated 1.660.5 and 0.160.1 colonies/10
5 transplanted
cells, respectively; the difference was statistically significant (Fig. 5D
and E). Thus, the Epcam KD treatment increased the concentra-
tion of SSCs in GS cell cultures.
Discussion
Although EPCAM has been considered as a homophilic cell
adhesion molecule, a series of recent studies has shown that
EPCAM, upon cleavage into small fragments, transmits prolifer-
ation signals [14,27,28]. The short intracellular domain EpICD
binds to a scaffolding protein, four-and-a-half LIM domains
protein 2, and is translocated into the nucleus, where it becomes
part of a large nuclear complex containing CTNNB1 and LEF1,
two components of the Wnt pathway. This causes upregulation of
MYC and cyclins, thereby facilitating proliferation. Consistent
with this, Epcam KD compromised proliferation of embryonic stem
(ES) cells [29]. EPCAM is also closely related to the maintenance
of the undifferentiated state; EPCAM was downregulated by
leukemia inhibitory factor (LIF) withdrawal, and KD treatment led
to extensive differentiation [29]. As exogenously expressed
EPCAM could only partially compensate for the requirement of
ES cells for LIF, EPCAM is considered to be essential, but not
sufficient for maintenance of the ES cell phenotype. Similar
observations have also been reported for human ES cells [30,31].
However, little progress has been made on the analyses of EPCAM
expression and its function in the germline.
In the present study, EPCAM expression changed dynamically
during SSC differentiation. We originally hypothesized that given
its strong expression on GS cells, EPCAM would be a useful
antigen for selection of a pure spermatogonial population from the
testis in order to initiate GS cell culture without contamination by
testicular somatic cells. However, EPCAM-selected cells had
limited clonogenic activity in vitro, and showed strong KIT
expression, suggesting that they were more enriched for progenitor
spermatogonia compared with CD9-selected cells. Double immu-
nostaining and transplantation of fractionated CD9-selected cells
revealed that CD9
+EPCAM
low/- cells showed little KIT expres-
sion, and had significantly increased SSC activity. These results
support the suggestion that EPCAM is gradually upregulated in
SSCs as they differentiate into progenitor spermatogonia in vivo.
EPCAM upregulation during SSC differentiation was unex-
pected, because EPCAM has been considered a useful marker for
SSCs, including those in rat and humans [11,32], and is strongly
expressed on mouse GS cells. In fact, EPCAM was reported to be
the best marker for rat SSCs [11]. Another study in rats also
demonstrated clonogenic activity of EPCAM-expressing gonocytes
[33]. Although these previous results strongly suggested that
EPCAM expression in SSCs is conserved across different species,
our results in mouse cells showed that EPCAM is regulated in a
more sophisticated manner, being most strongly expressed in
progenitor spermatogonia. The mechanism of SSC commitment
has been a major topic of recent SSC research, but the lack of
appropriate cell surface makers has prevented detailed analyses.
EPCAM appears to be a useful cell surface marker for
fractionating the spermatogonial compartment in studies of SSC
self-renewal and differentiation. Our results also underscore the
importance of functional transplantation studies based on the
quantitative assessment of cell surface marker expression levels. It
will be interesting to learn whether similar EPCAM expression
patterns are conserved during spermatogenesis in other animal
species.
The regulation and function of EPCAM were analyzed using
GS cells, a pure proliferating spermatogonial cell population.
EPCAM was upregulated by GDNF, suggesting that strong
EPCAM expression in GS cell cultures is attributable in part to
continuous exposure to GDNF, which is necessary for the
propagation of SSCs in vitro. In contrast, FGF2 showed no
apparent effect on EPCAM expression, although it is also an
indispensable cytokine for GS cell culture. In ES cells, EPCAM
Figure 4. Overexpression of EpICD in ROSA GS cells. (A) Upregulation of EPCAM by GDNF stimulation. ROSA GS cells were cultured on laminin
with 1% FBS and without cytokines for 3 days and then stimulated with the indicated cytokines. The cells were recovered 3 days after cytokine
stimulation, and stained with anti-EPCAM antibody. (B) Sorting of EpICD-transfected GS cells. GS cells (3610
5) on MEFs in 6-well plates were infected,
expanded in vitro, and sorted. (C) Morphology of the sorted cells. (D, E) Flow cytometric (D) and RT-PCR (E) analyses of EpICD-transfected ROSA GS
cells. No significant changes are seen. Green lines indicate controls. (F) Effects of cytokines on proliferation of EpICD-transfected ROSA GS cells.G S
cells (3610
5) on MEFs were cultured with the indicated cytokines and recovered by trypsinization 6 days after initiation of culture. No significant
differences are seen between the control and EpICD-transfected cells. (G) Quantification of colonies. No significant differences are seen between the
control and EpICD-transfected cells. (H) Macroscopic appearance of recipient testes. Recipient testes were stained with X-Gal 2 months after
transplantation. Blue tubules indicate germ cell colonies developed from donor SSCs. (I) Histological sections of recipient testes. Cells show
apparently normal spermatogenesis. Stain: X-Gal (H); X-Gal, Hematoxylin and eosin (I). Bars =100 mm (C), 1 mm (H), 20 mm (I).
doi:10.1371/journal.pone.0023663.g004
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PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e23663expression is upregulated by LIF. Thus, our results indicate that
the regulation of EPCAM expression differs between ES cells and
germline cells. In GS cell culture, LIF is useful for initiating
cultures from gonocytes, but is dispensable for establishment of GS
cells from spermatogonia. We also have not been able to observe a
positive effect of LIF on GS cell maintenance [34]. It may be that
EPCAM expression changes in accordance with the cytokine
milieu of the testicular micronevironment.
Although we did not find a significant effect of EpICD
overexpression, the downregulation of EpICD by Epcam KD
treatment significantly suppressed the GS cell recovery. This
suggested that EPCAM is involved in proliferation or survival of
spermatogonia. Interestingly, transplantation of Epcam KD cells
resulted in a relative enrichment of SSCs. Given the in vivo
expression pattern, these results suggest that EPCAM plays an
important functional role in progenitor cell compartment. At
present, very little is known about how progenitor spermatogonia
increase their numbers in vivo. KIT is one factor involved in
spermatogonial proliferation/survival [20]. Although its inhibition
by neutralizing antibody kills a large number of proliferating
spermatogonia [20], the inhibition of KIT signaling did not
interfere with GS cell proliferation [35]. Similarly, the addition of
KITL (Steel factor) did not enhance GS cell proliferation.
Therefore, KIT does not appear to be vital in GS cell
proliferation. The present results suggest that EPCAM may be a
good candidate for progenitor cell proliferation. Cell-to-cell
contact has been identified as an initial trigger for EPCAM
activation [27]; therefore, we speculate that upregulated EPCAM
on the cell surface may stimulate the proliferation of neighboring
spermatogonia by shedding extracellular domain of EPCAM,
thereby creating a positive feedback loop on proliferation signal in
an autocrine or paracrine fashion [14]. This provides an additional
stimulus to KIT, the ligand of which is expressed on Sertoli cells
[20]. The availability of two different stimuli in parallel may
perhaps contribute to the marked expansion of spermatogonia
progenitors during differentiation (Fig. 5F).
The fractionation of CD9-selected cells based on EPCAM
expression significantly improved the SSC purification efficiency.
Subfractionation of the CD9-selected cells resulted in more
efficient selection and achieved 48.7-fold enrichment. Assuming
that 10% of SSCs can colonize seminiferous tubules [5], the
frequency of SSCs in the suspension was 1 in 115 cells. Hence, this
method appears to be more efficient than the in vivo enrichment
method using cryptorchid testes, in which 1 in 161 cells were SSCs
[36]. The high SSC activity in CD9
+EPCAM
low/- cell population
was in agreement with stronger expression of several spermato-
gonia molecules implicated in SSC self-renewal, including Nanos3,
Bcl6b, and Etv5 [8,22]. However, the expression level of Nanos2,
which is thought to be expressed in the most undifferentiated
spermatogonia [21], was relatively weak in the same population,
possibly be due to its low expression level or the small population
size.
Previous attempts to enrich SSCs were based on cryptorchid
mouse models with only undifferentiated spermatogonia. Although
SSCs have now been purified to 1 in 15 to 30 cells by sorting of
cells from the cyptorchid testes, the preparation of cryptorchid
testes requires at least 2 months to remove differentiating germ
cells [36], and the technique may not be applicable to many
animal species due to differences in anatomical structures. We also
cannot exclude the possibility that SSCs in cryptorchid testes have
different biological characteristics from those in wild-type controls.
For example, a recent study showed that KIT-expressing
progenitor spermatogonia from wild-type testes can generate
SSCs [37]. This was in contrast to our previous study that showed
the absence of KIT on SSCs collected from cryptorchid testes [6].
In the present study, SSC activity was enriched in the
CD9
+EPCAM
low/- cell population, which consisted predominantly
of KIT
low/- cells. However, this population also contained some
KIT
2 cells. Although we recently reported that both KIT
2 and
KIT
+ cell populations in GS cell culture showed comparable levels
of SSC activity [35], only KIT
2cells showed SSC activity after
transplantation, which suggested that KIT expression on SSCs
may change according to their environment. Therefore, it is
important to establish methods to purify SSCs from wild-type
testes, and introduction of KIT as an additional marker may not
only reconcile these conflicting observations but also improve the
purification efficiency.
Ideally, the identification of SSC-specific antigens will greatly
advance our understanding of SSC biology, as the lack of such
markers has limited our knowledge regarding the regulation of
SSC self-renewal and differentiation. Although the morphological
description of spermatogonia has been well established, little
progress has been made in the functional analysis of this
compartment. Our results suggest that EPCAM is a useful marker
for characterizing the spermatogonial compartment, and our
analyses suggest that it plays an important role in spermatogonial
progenitor proliferation or survival. The future analysis of this
molecule will not only contribute to an improved SSC purification
strategy but also increase our knowledge of SSC commitment.
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Figure 5. Epcam KD in ROSA GS cells by shRNA. (A) Flow cytometric profile of ROSA GS cells 2 days after transduction with Epcam KD vector.
Green lines indicate controls. (B) Expression of EPCAM represented by the mean fluorescence intensity. Data are expressed as mean fluorescence
intensity minus background autofluorescence of cells stained with the control secondary antibody. (C) Reduced recovery of ROSA GS cells after
transduction with shRNA against Epcam. GS cells (8610
5) on MEFs were infected with the lentivirus and recovered 2 days later. Results of three
experiments are shown. (D) Macroscopic appearance of the recipient testes transplanted with Epcam KD GS cells. The same number of cells was
transplanted at the same time. Blue tubules indicate germ cell colonies developed from donor SSCs. (E) Assessment of SSC activity by germ cell
transplantation. ROSA GS cells were transplanted into the seminiferous tubules of W mice 3 days after transduction with shRNA against Epcam. (F) A
model for EPCAM function during SSC differentiation. GDNF upregulates EPCAM expression on SSCs/progenitors. Proliferation/survival of progenitors
may be stimulated by EPCAM expression on neighboring cells as well as by KITL on Sertoli cells. Stain: X-Gal (D). Bar =1 mm (D).
doi:10.1371/journal.pone.0023663.g005
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